May 17, 2022 / 04:00PM GMT
Peter S. Greenleaf - Aurinia Pharmaceuticals Inc. - President, CEO & Director
Good morning, and welcome to the 2022 Aurinia Pharmaceuticals Inc. Annual General Meeting. The meeting will now come to order. My name is Peter Greenleaf, and I'm the President and Chief Executive Officer of the corporation. Pursuant to the bylaws of the corporation, I will be acting as the Chairman of the meeting.
Due to the ongoing public health impact of the COVID-19 pandemic, this year's meeting is being held as a virtual meeting of shareholders. In addition to tabling our financial statements, there are 3 motions that we're going to be voting on today. All of the motions will be voted on, we will announce our preliminary voting results, and the business of the meeting will officially come to a close.
I will ask Stephen Robertson, Corporate Secretary of the corporation, to act as Secretary for this meeting, and I will ask Kyle Gould of Computershare Trust Company of Canada to act as scrutineer of the meeting. Would the Secretary please assure us that the Annual General Meeting has been properly called?
Aurinia Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers